AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 48 filers reported holding AUTOLUS THERAPEUTICS PLC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $950,000 | -66.8% | 500,000 | +181.6% | 0.20% | -47.8% |
| Q2 2019 | $2,858,000 | -52.9% | 177,546 | -8.0% | 0.39% | -29.4% |
| Q1 2019 | $6,074,000 | -8.9% | 192,994 | -4.9% | 0.55% | -26.2% |
| Q4 2018 | $6,666,000 | -25.4% | 202,994 | -31.5% | 0.75% | -26.8% |
| Q3 2018 | $8,935,000 | +89.5% | 296,251 | +68.3% | 1.03% | +57.8% |
| Q2 2018 | $4,716,000 | – | 176,045 | – | 0.65% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TFG Asset Management GP Ltd | 1,300,000 | $17,160,000 | 2.55% |
| Alphabet Inc. | 699,352 | $9,231,000 | 0.56% |
| DAFNA Capital Management LLC | 100,000 | $1,320,000 | 0.45% |
| JUPITER ASSET MANAGEMENT LTD | 705,356 | $9,311,000 | 0.29% |
| Artal Group S.A. | 500,000 | $6,600,000 | 0.26% |
| Cormorant Asset Management, LP | 479,988 | $6,336,000 | 0.25% |
| MPM BioImpact LLC | 39,740 | $525,000 | 0.19% |
| Granahan Investment Management | 305,158 | $4,028,000 | 0.18% |
| Burrage Capital Management LLC | 13,113 | $173,000 | 0.12% |
| Vident Investment Advisory, LLC | 118,866 | $1,569,000 | 0.10% |